-
Sep 3, 2025, 07:59
by
Full story
-
Sep 2, 2025, 01:00
by
User Not Found
Clinical Research News | A resurgence of research interest in psychedelics over the past 25 years might soon see compounds like psilocybin, otherwise known as “magic mushrooms,” finally having their day. In the clinical trial setting, dozens of studies are now underway testing psychedelics for the treatment of post-traumatic stress disorder (PTSD), depression, and, perhaps most commonly, substance abuse disorders (SUDs).
Full story
-
Aug 28, 2025, 10:02
by
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Full story
-
Aug 28, 2025, 10:02
by
Full story
-
Aug 28, 2025, 01:00
by
User Not Found
Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution.
Full story
-
Aug 27, 2025, 08:24
by
WCG announced the launch of WCG Total Training, the industry’s first end-to-end clinical trial training solution. The latest of WCG’s connected solutions, Total Training is purpose-built to unify live, virtual, hybrid, and on-demand training.
Full story
-
Aug 27, 2025, 01:00
by
User Not Found
Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more.
Full story
-
Aug 26, 2025, 01:00
by
User Not Found
Clinical Research News | The International Progressive MS Alliance launched its MS Clinical and Imaging Data Resource (CIDR); N-Power Medicine announced the launch of the industry’s first Prospective External Control Arm (ProECA) platform; and more.
Full story
-
Aug 22, 2025, 09:18
by
Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
Full story
-
Aug 21, 2025, 01:00
by
User Not Found
Clinical Research News | Radiopharmaceutical therapy (RPT) has been around for a long time now, but advances in technology and understanding of the actionable molecular pathways that drive cancer have fueled a resurgence in interest and investment in the therapeutic modality. he popularity of RPTs is driven largely by theranostics combining diagnostic imaging and targeted therapy into a single, integrated system to more precisely deliver radiation to tumor cells and thereby minimize damage to healthy tissue.
Full story
-
Aug 20, 2025, 09:21
by
MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.
Full story
-
Aug 20, 2025, 09:21
by
LabConnect has announced the launch of LabConnector™, a new technology designed to streamline and standardize laboratory data integration for clinical trials. LabConnector converts diverse lab data into a single HL7 format and enables bidirectional data exchange between sponsor organizations and participating labs. Built for IT and data teams, it allows faster, more accurate results to be delivered directly into Laboratory Information Management Systems (LIMS), improving flexibility, processing speed, and data reliability. The solution addresses challenges with data integration and quality, and helps sponsors adapt to evolving regulatory requirements and demand for faster, interoperable clinical data.
Full story
-
Aug 19, 2025, 08:21
by
Full story
-
Aug 19, 2025, 08:21
by
Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) awarded VaxHub Sustainable Grant to advance oral vaccine delivery in partnership with the University of Oxford’s Pandemic Sciences Institute.
The project, led by Professor Dame Sarah Gilbert at the University of Oxford’s Pandemic Sciences Institute, aims to induce mucosal immunity, improve vaccine stability, simplify distribution, and support self-administration.
Richard Johnson, Chief Scientific Officer at Upperton said: "Oral vaccine delivery has the potential to transform global immunisation and pandemic response strategies, and this project is a significant step forward where we can apply our formulation development expertise”.
Full story
-
Aug 19, 2025, 08:21
by
Full story
-
Aug 19, 2025, 01:00
by
User Not Found
Clinical Research News | Clinical trials and preclinical studies are demonstrating the therapeutic potential of Openwater's infrared light and low-intensity focused ultrasound technologies across a diverse range of medical conditions, from cancer treatment to stroke diagnosis.
Full story
-
Aug 14, 2025, 09:23
by
Syncell and Thermo Fisher Scientific are working together to bring a fully integrated, high-resolution spatial proteomics workflow to the market.
Full story
-
Aug 14, 2025, 01:00
by
User Not Found
Clinical Research News | The big holdup in the development of advanced medical devices seems inevitably to happen at the point where first-in-human clinical trials are to begin, at least if the studies are to be conducted in the U.S. where it can be difficult to find clinical leaders, recruit patients, and bear the overall financial burden of their execution.
Full story
-
Aug 13, 2025, 08:06
by
Full story
-
Aug 13, 2025, 01:00
by
User Not Found
Clinical Research News | Regardless of how one views the priorities of the Food and Drug Administration (FDA) under the new administration, it’s an opportunity for badly needed change to “shake things up,” according to Doug Bain, founder and consulting partner of UK-based ClinFlo, a newly launched consulting and service company focused on the application of technology to improve clinical research.
Full story